The role of clinical pharmacist on lipid control in dyslipidemic patients in North of Jordan

Tahaineh, Linda; Albsoul-Younes, Abla; Al-Ashqar, Eman; Habeb, Ala

doi:10.1007/s11096-011-9479-0

Cited by 23 publications

(35 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Sixty‐six studies were subsequently excluded because of study design, interventions not located in general practice setting, study protocol, conference abstract, no relevant outcome, interventions provided to primary healthcare physician and/or the pharmacist involved in collaboration with other healthcare providers. Finally, 21 RCTs contributed to the systematic review . Of these, 11 studies were included in the meta‐analysis.…”

Section: Resultsmentioning

confidence: 99%

“…The included studies were either cluster randomised controlled trials or were randomised controlled trials conducted in general practice. The studies were conducted in different countries including: 10 in USA, 4 in Canada, 3 in Brazil, and 1 each in Jordan, Chile, Malaysia and Thailand Appendix S2,. presents further characteristics of the studies included in this systematic review.…”

Section: Resultsmentioning

confidence: 99%

“…presents further characteristics of the studies included in this systematic review. Of the 21 included studies, 14 were included patients with diabetes, 7 with hypertension and 2 with dyslipidaemia . Pharmacists used multifaceted interventions including patient education, medication review and counselling, physical assessment (e.g.…”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Impact of the pharmacist‐led intervention on the control of medical cardiovascular risk factors for the primary prevention of cardiovascular disease in general practice: A systematic review and meta‐analysis of randomised controlled trials

Alshehri

Jalal

Cheema

et al. 2020

Brit J Clinical Pharma

View full text Add to dashboard Cite

Aims:To conduct a systematic review and meta-analysis of the effectiveness of general practice-based pharmacist interventions in reducing the medical risk factors for the primary prevention of cardiovascular events. Methods:A systemic search was undertaken in 8 databases: PubMed, MEDLINE, EMBAS, PsycINFO, Cochrane Library, CINAHL Plus, SCOPUS and Science Citation Index, with no start date up to 27 March 2019. Randomised controlled trials assessing the effectiveness of pharmacist-led interventions delivered in the general practice in reducing the medical risk factors of cardiovascular events were included in the review. The risk of bias in the studies was assessed using the Cochrane risk of bias tool. Results: A total of 1604 studies were identified, with 21 randomised controlled trials (8933 patients) meeting the inclusion criteria. Fourteen studies were conducted in patients with diabetes, 7 in hypertension, 2 involving dyslipidaemia, and 2 with hypertension and diabetes together. The most frequently used interventions were medication review and medication management. The quality of the included studies was variable. Patients receiving pharmacist-led interventions were associated with a statistically significant reduction in their systolic blood pressure (−9.33 mmHg [95% Confidence Interval (CI) −13.36 to −5.30]), haemoglobin A1C (−0.76% [95% CI −1.15 to −0.37]) and low-density lipoprotein-cholesterol (−15.19 mg/dL [95% CI −24.05 to −6.33]). Moreover, practice-based pharmacists' interventions were also reported to have a positive impact on patient adherence to medications. Conclusion:The findings of this review suggest that pharmacist-led interventions in general practice can significantly reduce the medical risk factors of cardiovascular disease events. These findings support the involvement of pharmacists as healthcare providers in managing patients with hypertension, diabetes and dyslipidaemia. K E Y W O R D Scardiovascular disease, general practice, pharmacist PI statement: The authors confirm that the Principal Investigator for this paper is Abdullah A. Alshehri and that he had direct clinical responsibility for patients.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Impact of the pharmacist‐led intervention on the control of medical cardiovascular risk factors for the primary prevention of cardiovascular disease in general practice: A systematic review and meta‐analysis of randomised controlled trials

Alshehri

Jalal

Cheema

et al. 2020

Brit J Clinical Pharma

View full text Add to dashboard Cite

show abstract

“…Clinical pharmacy is a relatively new concept in Jordan. A number of studies have investigated clinical pharmacists’ roles in improving health outcomes in different disease states and different settings in Jordan . The main aim of this study was to investigate the role of the clinical pharmacist in the health outcomes of IDA patients in Jordan.…”

Section: Introductionmentioning

confidence: 99%

“…A number of studies have investigated clinical pharmacists' roles in improving health outcomes in different disease states and different settings in Jordan. [14][15][16] The main aim of this study was to investigate the role of the clinical pharmacist in the health outcomes of IDA patients in Jordan. The objective of this study was to evaluate the impact of clinical pharmacy services such as interventions and patients counselling on haemoglobin (Hgb) levels of IDA patients in Jordan.…”

Section: Introductionmentioning

confidence: 99%

A randomised control trial to evaluate the clinical pharmacist's role in managing iron deficiency anaemia patients

Tahaineh

Khasawneh

2017

International Journal of Pharmacy Practice

View full text Add to dashboard Cite

Objective To investigate the role of clinical pharmacists in managing iron deficiency anaemia patients. Methods A prospective parallel randomised controlled trial conducted in an outpatient clinic enrolled adult iron deficiency anaemia patients. Patients were randomised into either an intervention or a control group. Patients in the intervention group were followed closely by a clinical pharmacist who offered pharmaceutical care services and worked closely with physicians to manage iron deficiency anaemia. Patients in the control group received the usual medical care.

show abstract

The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries

Pande

Hiller

Nkansah

et al. 2013

Cochrane Database of Systematic Reviews

116

127

View full text Add to dashboard Cite

show abstract

The role of clinical pharmacist on lipid control in dyslipidemic patients in North of Jordan

Abstract: Implementing clinical pharmacy services in Jordan has improved the lipid profiles of dyslipidemic patients.

Cited by 23 publications

References 18 publications

Impact of the pharmacist‐led intervention on the control of medical cardiovascular risk factors for the primary prevention of cardiovascular disease in general practice: A systematic review and meta‐analysis of randomised controlled trials

Impact of the pharmacist‐led intervention on the control of medical cardiovascular risk factors for the primary prevention of cardiovascular disease in general practice: A systematic review and meta‐analysis of randomised controlled trials

A randomised control trial to evaluate the clinical pharmacist's role in managing iron deficiency anaemia patients

The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries

Contact Info

Product

Resources

About